Selective RET kinase inhibition for patients with RET-altered cancers
Author:
Funder
National Institutes of Health Cancer Center
Cancer Prevention Research Institute of Texas
National Center for Advancing Translational Sciences
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/29/8/1869/25505003/mdy137.pdf
Reference27 articles.
1. The landscape of kinase fusions in cancer;Stransky;Nat Commun,2014
2. Identification of driving ALK fusion genes and genomic landscape of medullary thyroid cancer;Ji;PLoS Genet,2015
3. RET aberrations in diverse cancers: next-generation sequencing of 4,871 patients;Kato;Clin Cancer Res,2017
4. Activation of a novel human transforming gene, ret, by DNA rearrangement;Takahashi;Cell,1985
5. Multiple endocrine neoplasia type 2B mutation in human RET oncogene induces medullary thyroid carcinoma in transgenic mice;Acton;Oncogene,2000
Cited by 332 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Assessing the Effectiveness of Selective RET Inhibitors in RET-Positive Cancers through Fluorodeoxyglucose Uptake Analysis;Diagnostics;2024-08-28
2. Mechanisms of resistance to tyrosine kinase inhibitor‐targeted therapy and overcoming strategies;MedComm;2024-08-24
3. Non-Small-Cell Lung Cancers (NSCLCs) Harboring RET Gene Fusion, from Their Discovery to the Advent of New Selective Potent RET Inhibitors: “Shadows and Fogs”;Cancers;2024-08-19
4. Association of 18F- fluorodeoxyglucose uptake with the expression of metabolism-related molecules in papillary thyroid cancer;Auris Nasus Larynx;2024-08
5. Novel therapeutic strategies targeting bypass pathways and mitochondrial dysfunction to combat resistance to RET inhibitors in NSCLC;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3